Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
US/PA/E Imaging for Early Tumor Response in Neoadjuvant TNBC
NCT07862751Phase 2Not yet recruiting
- Sponsor
- Emory University
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Emory University. Primary endpoint: Serial changes in the ultrasound/photoacoustic/elasticity (US/PA/E) imaging biomarkers at 24 weeks. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07862751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07862751.